A Clinical Study of CD19 CAR-T in Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Conditions: Systemic Lupus Erythematosus Interventions: Biological: CD19 CAR-T cell infusion Sponsors: Wuhan Union Hospital, China; Guangzhou Bio-gene Technology Co., Ltd Not yet recruiting

https://clinicaltrials.gov/study/NCT06106906

Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials